News from oramed pharmaceuticals inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 16, 2013, 09:15 ET

Oramed Pharmaceuticals Appoints New Chief Operating Officer and VP of Business Development

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, today announced a key addition to...

Apr 11, 2013, 03:11 ET

Oramed Submits New IND Application for Oral Insulin Trial in the US

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has...

Apr 03, 2013, 07:45 ET

Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has...

Mar 21, 2013, 09:15 ET

Oramed Pharmaceuticals Selected to Present at the 73rd Scientific Sessions of the American Diabetes Association in Chicago, IL, June 21-25, 2013

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that its...

Feb 18, 2013, 09:15 ET

Oramed Pharmaceuticals to Present at the 4th Annual Drug Delivery & Formulation Summit in Berlin

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral delivery systems, announced today that Dr. Ehud Arbit,...

Feb 14, 2013, 09:27 ET

Oramed Pharmaceuticals Moves Forward with Investigational New Drug Application for Oral Insulin

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has been in...

Feb 11, 2013, 09:45 ET

Oramed Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that their February...

Feb 07, 2013, 08:30 ET

Shares of Oramed Pharmaceuticals Are Approved for Listing on the Nasdaq Capital Market

Oramed Pharmaceuticals Inc. (OTCQB: ORMPD), a developer of oral drug delivery systems, announced today that NASDAQ has approved the company's...

Feb 05, 2013, 07:00 ET

Oramed Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on February 7th

Oramed Pharmaceuticals Inc. (OTC:ORMPD) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that Nadav Kidron,...

Jan 22, 2013, 16:30 ET

Oramed Pharmaceuticals Announces Reverse Stock Split

Oramed Pharmaceuticals Inc. (OTCQB:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that its previously...

Jan 07, 2013, 09:20 ET

Oramed Pharmaceuticals Files Investigational New Drug Application with the FDA for Oral Insulin

Oramed Pharmaceuticals Inc. (OTCBB:ORMP.OB) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has filed...

Dec 11, 2012, 09:20 ET

Oramed Pharmaceuticals Completes $5.6 Million Funding to Advance Clinical Trials

Oramed Pharmaceuticals Inc. (OTCBB:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has completed...

Nov 07, 2012, 09:20 ET

Oramed Pharmaceuticals to Present at the 12th Annual Diabetes Technology Society Meeting in Bethesda, MD, Nov 8-10, 2012

Oramed Pharmaceuticals Inc. (OTCBB: ORMP; www.oramed.com), a developer of oral delivery systems, announced today that results of a study performed...

Oct 18, 2012, 09:20 ET

Former Johnson & Johnson and Bausch & Lomb Executive, Gerald Ostrov, Joins Oramed Pharmaceuticals' Board of Directors

Oramed Pharmaceuticals Inc. (OTCBB:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that Gerald Ostrov,...

Oct 03, 2012, 09:20 ET

Oramed Pharmaceuticals to Collaborate With Leading Contract Research Organization Medpace for Phase II FDA Trial on Oral Insulin

Oramed Pharmaceuticals Inc. (OTCBB:ORMP.OB) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that its...

Jul 11, 2012, 09:20 ET

Oramed Pharmaceuticals Granted 2nd Patent in New Zealand; 3rd Patent for Core Technology on Oral Delivery of Proteins

Announcing its third patent approval since the beginning of the calendar year, Oramed Pharmaceuticals Inc. (OTCBB:ORMP.OB) (www . oramed . com), a...

Jun 04, 2012, 09:20 ET

Oramed Pharmaceuticals to Present at the 72nd Scientific Sessions of the American Diabetes Association in Philadelphia, PA, June 8-12, 2012

Oramed Pharmaceuticals (OTCBB: ORMP.OB), a developer of oral delivery systems, announced today that its abstract, "Concomitant oral...

May 29, 2012, 09:26 ET

Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has...

May 21, 2012, 05:24 ET

Oramed Pharmaceuticals to Present at the 11th National Life Science & Technology Week ILSI-BIOMED Conference; Tel Aviv, Israel, 2012

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB), a developer of oral delivery systems, announced today that it was chosen to present at the...

Feb 07, 2012, 09:20 ET

Oramed Pharmaceuticals Announces Educational Lecture at the National University Hospital in Singapore

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery systems, announced today that Dr Miriam Kidron,...